A white paper that provides evidence of the positive effects of post-curing on the reduction of cyclosiloxane contamination in silicone tubing manufacture has been published by Watson-Marlow Fluid Technology Group (WMFTG).
With the increased amount of biological products coming to the market, new practices to provide greater assurance on pharmaceutical sterilisation processes are necessary.
Kancera has applied for approval of a Phase I trial for its drug candidate, KAND567, which blocks the fractalkine system. The study will be performed in collaboration with the clinical contract company QPS in the Netherlands.
For coated elastomeric closures, barrier properties alone are no longer enough to meet the needs of biologic drug packaging. Dr Susan Dounce, senior manager, business development and innovation, injection systems, Datwyler Sealing Solutions writes.
A recent report from MarketIntelReports — ‘World Intravenous (IV) Ibuprofen Market — Opportunities and Forecast 2022’ — has estimated that the IV ibuprofen market will register a compound annual growth rate of 20% until 2022.
It has been announced that Chemische Fabrik Budenheim site in Budenheim, Germany, has recently been awarded an EXCiPACT GMP/GDP certificate from SGS — one of EXCiPACT’s internationally recognised certification bodies.
Andrew Mitchell, VP Life Sciences & Healthcare EMEA, DHL Customer Solutions & Innovation Logistics group discusses how to adapt under pressure to create more speed and reliability in the supply chain.
